Bio Rad Laboratories Stock Alpha and Beta Analysis
| BIO Stock | USD 256.68 2.21 0.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bio Rad Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bio Rad over a specified time horizon. Remember, high Bio Rad's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bio Rad's market risk premium analysis include:
Beta 0.94 | Alpha (0.33) | Risk 2.32 | Sharpe Ratio (0.16) | Expected Return (0.38) |
Bio Rad Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Bio |
Bio Rad Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bio Rad market risk premium is the additional return an investor will receive from holding Bio Rad long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio Rad. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bio Rad's performance over market.| α | -0.33 | β | 0.94 |
Bio Rad expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bio Rad's Buy-and-hold return. Our buy-and-hold chart shows how Bio Rad performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Bio Rad Market Price Analysis
Market price analysis indicators help investors to evaluate how Bio Rad stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Rad shares will generate the highest return on investment. By understating and applying Bio Rad stock market price indicators, traders can identify Bio Rad position entry and exit signals to maximize returns.
Bio Rad Return and Market Media
The median price of Bio Rad for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 is 327.47 with a coefficient of variation of 12.77. The daily time series for the period is distributed with a sample standard deviation of 39.73, arithmetic mean of 311.17, and mean deviation of 36.11. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 279 shares by Andrew Last of Bio Rad at 4.6 subject to Rule 16b-3 | 01/23/2025 |
2 | Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO Investor Conference | 02/06/2025 |
3 | Disposition of 298 shares by Michael Crowley of Bio Rad at 4.6 subject to Rule 16b-3 | 02/14/2025 |
4 | BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of blue... | 02/25/2025 |
5 | 21 Billion Microfluidic Device Systems Market Analysis 2030 Tripling in Size from 2024 | 02/27/2025 |
6 | Staar Surgical, BD, Acutus Medical announce layoffs in Southern California | 02/28/2025 |
7 | Fisher Asset Management LLC Grows Stock Holdings in Bio-Rad Laboratories, Inc. | 03/03/2025 |
8 | Bio-Rad Laboratories Inc Trading 3.6 percent Higher on Mar 5 | 03/05/2025 |
9 | Japan In-Vitro Diagnostics Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, Danaher, Biomerieux, Roche, Becton, Sysmex, Bio-Rad Laborator... | 03/07/2025 |
10 | Proteomics Market Projected To Witness Substantial Growth, 2025-2032 Bio-Rad Laboratories, Inc., GE Healthcare, Bruker | 03/10/2025 |
11 | MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand | 03/12/2025 |
12 | Disposition of tradable shares by Allison Schwartz of Bio Rad at 4.6 subject to Rule 16b-3 | 03/14/2025 |
About Bio Rad Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bio or other stocks. Alpha measures the amount that position in Bio Rad Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Days Sales Outstanding | 64.43 | 66.82 | 76.84 | 87.31 |
| PTB Ratio | 1.3 | 1.08 | 1.41 | 2.13 |
Bio Rad Upcoming Company Events
As portrayed in its financial statements, the presentation of Bio Rad's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Rad's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bio Rad's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bio Rad. Please utilize our Beneish M Score to check the likelihood of Bio Rad's management manipulating its earnings.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Bio Rad
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Bio Rad Backtesting, Bio Rad Valuation, Bio Rad Correlation, Bio Rad Hype Analysis, Bio Rad Volatility, Bio Rad History and analyze Bio Rad Performance. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Bio Rad technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.